Omalizumab substantially improves dermatology‐related quality of life in patients with chronic spontaneous urticaria

BACKGROUND: Chronic spontaneous/idiopathic urticaria (CSU/CIU) has substantial detrimental effects on health‐related quality of life (HRQoL) with an effect comparable to or worse than many other skin diseases. OBJECTIVE: To assess the effect of omalizumab on CSU patients' HRQoL, measured by the...

Descripción completa

Detalles Bibliográficos
Autores principales: Finlay, A.Y., Kaplan, A.P., Beck, L.A., Antonova, E.N., Balp, M.‐M., Zazzali, J., Khalil, S., Maurer, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles and Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697571/
https://www.ncbi.nlm.nih.gov/pubmed/28573683
http://dx.doi.org/10.1111/jdv.14384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697571/
https://www.ncbi.nlm.nih.gov/pubmed/28573683
http://dx.doi.org/10.1111/jdv.14384

Ejemplares similares